Physician profile
Joseph Lee
NPI 1922098201
$19,571.51
in general payments reported to CMS, 2019-2025
35 companies · $3,194 in 2025
The $3,194 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $506 · 2021: $736 · 2022: $9,609 · 2023: $2,688 · 2024: $2,340 · 2025: $3,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,569 · Travel and Lodging: $1,353 · Consulting Fee: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,569.46 |
| Travel and Lodging | $1,353.26 |
| Consulting Fee | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,825.24 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Affera Mapping System |
| Abbott Laboratories | $2,166.78 | 2019-2025 | Aveir, Jot Dx, Ensite |
| E.R. Squibb & Sons, L.L.C. | $633.40 | 2022-2025 | Camzyos, Eliquis |
| Cvrx, INC. | $527.97 | 2020-2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $519.39 | 2022-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $406.90 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $376.26 | 2023-2025 | Lifevest |
| Boston Scientific Corporation | $361.64 | 2019-2025 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor, Cds - Mct/Cem Monitoring |
| Novo Nordisk INC | $325.18 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Scpharmaceuticals INC. | $293.10 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $282.43 | 2019-2023 | |
| Kestra Medical Technology Services, INC. | $260.33 | 2023-2025 | Assure Wcd |
| Heartflow, INC. | $227.61 | 2024 | |
| Pfizer INC. | $226.45 | 2019-2025 | |
| Biosense Webster, INC. | $200.33 | 2019-2025 | Carto 3 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.81 | 2022-2025 | Jardiance |
| Medtronic Vascular, INC. | $158.80 | 2020 | |
| Atricure, INC. | $152.41 | 2022 | |
| Bridgebio Pharma, INC. | $144.43 | 2025 | Attruby |
| Zoll Respicardia, INC. | $136.39 | 2021 | |
| Amarin Pharma, INC. | $125.00 | 2019 | |
| Lilly USA, LLC | $124.51 | 2025 | |
| Ionis Pharmaceuticals, INC. | $122.03 | 2025 | Tryngolza |
| Bayer Healthcare Pharmaceuticals INC. | $118.98 | 2025 | |
| Cardiva Medical, INC. | $118.87 | 2020 | |
| Esperion Therapeutics, INC. | $115.60 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $82.62 | 2024 | |
| Amgen INC. | $78.40 | 2023-2024 | Repatha |
| Philips North America LLC | $72.14 | 2020-2021 | |
| Baxter Healthcare | $66.11 | 2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Merck Sharp & Dohme LLC | $61.73 | 2023 | Verquvo |
| Recor Medical INC | $28.00 | 2025 | Paradise Ultrasound Renal Denervation System |
| Abiomed | $22.62 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $21.84 | 2023 | Farxiga |
| Kowa Pharmaceuticals America, INC. | $16.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.